Pifexole
CAS: 27199-40-2
Ref. 3D-CBA19940
| 1g | To inquire | ||
| 5g | To inquire | ||
| 10g | To inquire | ||
| 250mg | To inquire | ||
| 500mg | To inquire |
Product Information
Pifexole is a potent anticancer drug that acts as an inhibitor of cyclin-dependent kinases (CDKs) and protein kinase B (AKT). This drug has been shown to induce apoptosis in cancer cells and inhibit tumor growth. Pifexole is derived from a Chinese medicinal plant, and its analog has been found in human urine. It targets CDKs and AKT, which are involved in the regulation of cell cycle progression and survival, respectively. Pifexole inhibits these enzymes, leading to cell death and preventing further growth of cancer cells. This drug has shown promising results in preclinical studies for various types of cancers, including breast, lung, and prostate cancer. Additionally, Pifexole has minimal toxicity compared to other anticancer drugs currently available on the market. Overall, Pifexole is a promising new therapy for cancer treatment with potential for significant impact on patient outcomes.
Chemical properties
Technical inquiry about: 3D-CBA19940 Pifexole
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
